PTC Therapeutics, Inc. (PTCT)
NASDAQ · Healthcare
PTC Therapeutics, Inc. Operating Income 2011–2025
PTC Therapeutics, Inc. annual/quarterly operating income history and growth rate from 2011 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- PTC Therapeutics, Inc. operating income for the quarter ending March 31, 2026 was 45.0 M, a 95.37% decrease year-over-year.
- PTC Therapeutics, Inc. operating income for the twelve months ending March 31, 2026 was 983.2 M, a 480.59% decrease year-over-year.
- PTC Therapeutics, Inc. annual operating income for 2025 was 866.9 M, a 386.52% decrease from 2024.
- PTC Therapeutics, Inc. annual operating income for 2024 was -302.6 M, a 31.16% decrease from 2023.
- PTC Therapeutics, Inc. annual operating income for 2023 was -439.5 M, a 1.77% decrease from 2022.
- PTC Therapeutics, Inc. annual operating income for 2022 was -447.4 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Ptc Therapeutics Inc. Operating Income — FAQ
Ptc Therapeutics Inc. (PTCT) operating income over the last 15 years — annual and quarterly figures with year-over-year growth and charts.
What is Ptc Therapeutics Inc.'s operating income?
Ptc Therapeutics Inc. (PTCT) reported operating income of $867M for fiscal 2025.
Where can I see PTCT's operating income history?
The chart and table above show Ptc Therapeutics Inc.'s operating income by year and by quarter, including the growth rate.